Compliance with good manufacturing practice (“GMP”) is mandatory for all medicinal products that have been granted a marketing authorisation. Likewise, the manufacture of investigational medicinal products must be in accordance with GMP. Advanced therapy medicinal products that are administered to patients under Article 3 of Directive 2001/83/EC (so called “hospital exemption”) must be manufactured under equivalent quality standards to the manufacturing of advanced therapy medicinal products with a marketing authorisation.
Article 5 of Regulation (EC) No 1394/2007 mandates the Commission to draw up guidelines on good manufacturing practice specific to advanced therapy medicinal products ("ATMPs"). Article 63(1) of Regulation (EU) No 536/2014 also empowers the Commission to adopt and publish detailed guidelines on good manufacturing practice applicable to investigational medicinal products.
EC 22.11.2017
EudraLex 22.11.2017
An accident is a sudden event that is not planned or intended and that causes damage or injury.
An incident is a sudden e...
Il regolamento REACH si fonda sul principio che spetta al settore industriale garantire che le sostanze che fabbrica, immette sul mercato o utilizza non abbia...
Regolamento (UE) 2021/850 della Commissione del 26 maggio 2021 che modifica e rettifica l’allegato II e che modifica gli allegati III, IV e VI del regolamento (CE) n. 1223/200...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
